Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nuvo Pharmaceuticals Inc
MRVFF
Healthcare
Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.
ts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQX:MRVFF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 11, 2020 10:20am
Q1 highlights
Q1 2020 Financial Highlights For the three months ended March 31, 2020, adjusted total revenue(1) was $18.9 million, an increase of 11% compared to $17.1 million for the three
...more
(1)
•••
Marathon11
X
View Profile
View Bullboard History
Comment by
Marathon11
on May 11, 2020 9:51am
RE:RE:Insider buying continues
My guess is Buyout. Employment Agreements in the latest annual report with big payouts for "change of control". Contract for Harris (Chairman) was for 2019 but has been extended for 2020. In
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Comment by
ValueCap
on May 08, 2020 11:52pm
RE:Earnings Monday
I kind of hope the stock drops to 50 cents again so I can buy more lol.
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Post by
ValueCap
on May 08, 2020 9:25pm
Earnings Monday
What to expect? I think the comp from last year Q1 2019 as a baseline for Q1 2020, with adjusted revenue of 17.1 million, adjusted ebitda of 5.1 million. Blexten and Cambia will have
...more
(1)
•••
UglyKidStock
X
View Profile
View Bullboard History
Comment by
UglyKidStock
on Mar 28, 2020 11:46am
RE:Insider buying continues
Of all of the stock bargains available in the market after this crash NRI insiders have bought their companies stock. 80,000 shares since earnings report. Not a ton of money but a
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 04, 2020 6:12pm
RE:Launch of Generic Version of Vimovo in the United States
Maybe Dr Reddy has made a calculated risk. Begin sales now and grow big time and budget for a settlement with Nuvo of say $10 million US which Nuvo would probably agree to.
(14)
•••
midard
X
View Profile
View Bullboard History
Post by
midard
on Mar 04, 2020 5:22pm
Launch of Generic Version of Vimovo in the United States
ORIGINAL: Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States 2020-03-04 17:05 ET - News Release
...more
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Post by
ValueCap
on Mar 03, 2020 7:50pm
Insiders Buying
https://m.canadianinsider.com/node/7?menu_tickersearch=NRI+%7C+Nuvo+Pharmaceuticals+
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 29, 2020 3:43pm
RE:Target Price
$2.30..... https://www.bloomburton.com/research/NRI20200226.pdf
(1)
•••
Marathon11
X
View Profile
View Bullboard History
Post by
Marathon11
on Feb 29, 2020 11:35am
Target Price
Has BB published a new target price? Resultz US will be a big big deal in my opinion. Holding and accumulating until 2024-2025.
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Feb 27, 2020 7:36pm
Health Canada approval
https://www.newswire.ca/news-releases/nuvo-pharmaceuticals-r-announces-health-canada-approves-suvexx-tm-for-the-acute-treatment-of-migraine-842721618.html
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Feb 25, 2020 11:17pm
Transcript
https://seekingalpha.com/article/4326938-nuvo-pharmaceuticals-inc-nriff-ceo-jesse-ledger-on-q4-2019-results-earnings-call-transcript?part=single
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Feb 25, 2020 9:41am
Presentation
https://www.nuvopharmaceuticals.com/wp-content/uploads/2020/02/02-25-2020_Investor-Presentation.pdf
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 25, 2020 9:13am
RE:Great quarter and year end
synergies of merger too....
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Post by
ValueCap
on Feb 25, 2020 8:01am
Great quarter and year end
8.6 million quarterly ebitda vs estimate 7.8. Annual ebitda 28.1 million vs 26.1 estimate Great Blexten and Cambia growth. Swiss approval of Pennsaid 2% and launch this year
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden